The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
INSULINS
Abstract
More than ever before in the history of diabetes therapy, patients and health care providers have the necessary pharmacologic tools available to achieve near-normal blood glucose control. Achievement of this goal, however, requires an in-depth knowledge of the pharmacology and limitations of the currently available insulins. A willingness to try new strategies combined with a creative approach to each patient will result in optimal diabetes management. Continued advances in the development of insulin analogues and investigation into alternative routes of insulin delivery are likely to expand therapeutic options in the near future. Such developments will continue to improve the quality of life and health of patients with diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Very low values are seen in patients treated exclusively with human recombinant insulin (377).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [377]
Citations
Cites
Current estimates from the National Health Interview Survey.
Ss, J. (1981) · PubMed · Cited by 1,866
Current estimates from the National Health Interview Survey, 1990.
Adams, P. F., Hendershot, G. E., & Marano, M. A. (1987) · PubMed · Cited by 1,104
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Berson, S. A., Yalow, R. S., Bauman, A., Rothschild, M. A., & Newerly, K. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103262 · Cited by 836
Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis
Weiner, H. L., Mackin, G. A., Matsui, M., Orav, E. J., Khoury, S. J., Dawson, D. M., & Hafler, D. A. (1993) · Science · doi:10.1126/science.7680493 · Cited by 584
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Zhang, Z. J., Davidson, L., Eisenbarth, G., & Weiner, H. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10252 · Cited by 563
[Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin
Howey, D. C., Bowsher, R. R., Brunelle, R. L., & Woodworth, J. R. (1994) · Diabetes · doi:10.2337/diab.43.3.396 · Cited by 472
Monomeric Insulins and Their Experimental and Clinical Implications
Brange, J., Owens, D. R., Kang, S., & Vølund, A. (1990) · Diabetes Care · doi:10.2337/diacare.13.9.923 · Cited by 369
Prehepatic Insulin Production in Man: Kinetic Analysis Using Peripheral Connecting Peptide Behavior*
EATON, R. P., ALLEN, R. C., SCHADE, D. S., ERICKSON, K. M., & STANDEFER, J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-520 · Cited by 363
Self-citationInsulin transport across capillaries is rate limiting for insulin action in dogs.
Yang, Y. J., Hope, I. D., Ader, M., & Bergman, R. N. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114339 · Cited by 303
Research works printed but not linked: 17
- Anderson, 1994, Safety of [Lys(B28),Pro(B29)] human insulin analog in long-term clinical trials, Diabetes, 43, 61A
- Anderson, 1996, Reduced frequency of hypoglycemia without loss of glycemic control, Diabetes, 45, 59A
- Anonymous, 1997, Insulin adminstration: American Diabetes Association Clinical Practice Recommendations, Diabetes Care, 20, S46
- Banting, 1922, The preparation of pancreatic extracts containing insulin, Trans R Soc Can, Section V
- Bastyr, 1996, Insulin Lispro reduces hypoglycemia rate in persons with type II diabetes at high risk for hypoglycemia, Diabetes, 45, 56A
- Garg, 1995, Pre-meal insulin analogue insulin Lispro vs. humulin R insulin treatment in young subjects with type I diabetes, Diabet Med, 12, 1
- Hallas-Moller, 1957, Clinical investigations on new insulin preparations with protracted action: Insulin-zinc preparations used in one daily injection, Ugeskr Laeger, 113, 1767
- Higenfeld, 1992, Controlling insulin bioavailability by crystal contact engineering, Diabetologia, 35, A193
- Hilsted, 1996, Clinical consequences of intranasal therapy in insulin-dependent diabetes mellitus, Ugeskr Laeger, 158, 3451
- Krayenbuhl, 1946, Cyrstalline protamine insulin, Rep Steno Mem Hosp, 1, 60
- Laube, 1992, Aerosolized insulin delivered through the lungs is effective in normalizing plasma glucose levels in non–insulin-dependent diabetic subjects, J Biopharm Sci, 3, 163
- News, 1996, NIH tests insulin capsule to prevent type 1 diabetes, NIDDK
- Schernthaner, 1983, Immunogenicity of human insulin or pork monocompetent insulin in HLA-DR-typed insulin-dependent diabetic individuals, Diabetes Care, 6, 43
- Seigler, 1991, Pharmacokinetics of long-acting (Ultralente) insulin preparations, Diabetes Nutr Metab, 4, 267
- Seipke, 1992, New insulin preparations with prolonged action profiles: A21-modified arginine insulins, Diabetologia, 35, A4
- Talaulicar, 1994, Efficacy of HOE 901 following subcutaneous injection for four days in type I diabetic subjects, Diabetologia, 37, A78
- Vignati, 1994, Efficacy of [Lys(B28),Pro(B29)] human insulin in a one year global randomized clinical trial, Diabetes, 43, 78A
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Type 2 Diabetes Mellitus: A Review of Current Trends
Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012) · Oman Medical Journal · doi:10.5001/omj.2012.68 · Cited by 1,338
Sacks, D. B., Bruns, D. E., Goldstein, D. E., Maclaren, N. K., McDonald, J. M., & Parrott, M. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.436 · Cited by 1,130
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Diabetes Care · doi:10.2337/dc11-9998 · Cited by 718
Metadata
- Authors
- Burge, M. R., & Schade, D. S.
- Affiliations
- University of New Mexico (US)
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 1997-09
- Volume
- 26
- Issue
- 3
- Pages
- 575-598
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W4254805854
- Cited by
- 48
- References
- 90
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2017: 2 · 2015: 1 · 2014: 1 · 2012: 1
- FWCI
- 0.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrinology and Metabolism Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin, insulin analogues, diabetes mellitus, glycemic control, insulin pharmacology, insulin delivery route, diabetes management
- MeSH terms
- Animals, Cattle, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin, Swine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: INSULINS. https://app.cochat.ai/papers/10.1016/s0889-8529(05)70268-1
- The paper
- Burge, M. R., & Schade, D. S. (1997). INSULINS. Endocrinology and Metabolism Clinics of North America. https://doi.org/10.1016/s0889-8529(05)70268-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.